Faculty
Please select a name to view that person's profile information.
Justin Annes, M.D.Clinical Genetics Brigham and Women's Hospital
|
Gerard T. Berry, M.D.Director, Medical Biochemical Genetics Specialty; Co-Director, Clinical Biochemical Genetics Specialty Gerard T. Berry, MD is co-director of the Clinical Biochemical Genetics program and director of the Medical Biochemical Genetics program. Dr. Berry specializes in biochemical genetics (metabolism). He is the Diretor of the Metabolism Program at Children’s Hospital Boston and Professor of Pediatrics at Harvard Medical School. Dr. Berry holds Board Certifications in Pediatrics, Biochemical Genetics, and Pediatric Endocrinology.
|
Frederick Bieber, Ph.D.Cytogenetics Brigham and Women's Hospital
|
Gerald Cox, M.D.Clinical Genetics Children's Hospital Boston
|
Paola Dal Cin, Ph.D.Cytogenetics Brigham and Women's Hospital |
Natasha Frank, M.D.Clinical Genetics Brigham and Women's Hospital |
Birgit Funke, Ph.D.Molecular Genetics Laboratory for Molecular Medicine, Partners HealthCare Center for Personalized Genetic Medicine
|
 |
Judy Garber, M.D.Director of Cancer Genetics and Prevention Disease Center Dana-Farber Cancer Institute Judy E. Garber, M.D., MPH, is Director of the new Cancer Genetics and Prevention Disease Center at the Dana-Farber Cancer Institute. She is attending physician at Dana-Farber’s Breast Oncology Center, an associate physician at Brigham and Women’s Hospital and an associate professor of Medicine at Harvard Medical School. Dr. Garber is currently president-elect of American Association for Cancer Research, the largest organization of cancer researchers in the world. She is a member of the NCI Board of Scientific Counselors and chairs the External Advisory Board of the SPORE in Breast Cancer at MD Anderson Cancer Center. She serves on the Scientific Advisory Board of the Breast Cancer Research Foundation and is a member or chair of the Data Safety Monitoring Committees of several international breast cancer clinical trials. Locally, she co-chairs a Dana-Farber/Harvard Cancer Center Institutional Review Board panel D, and is a member of the Personalized Cancer Medicine Partnership Steering Committee and Executive Committee for Clinical Research. To foster the incorporation of cancer genetics into clinical practice, Dr. Garber has played a major role in the development of national guidelines in genetics (American College of Medical Genetics) and medical oncology (American Society of Clinical Oncology and National Comprehensive Cancer Network.) Her research activities include the study of breast cancer risk assessment and communication, cancer genetics more broadly, and pharmacogenetics. She is also a leader in research into the characteristics and treatment of triple negative or basal-like breast cancer, the most common form in women with BRCA1 mutations. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers. |
Anne Giersch, Ph.D.Cytogenetics Brigham and Women's Hospital |
David Harris, M.D.Clinical Genetics Children's Hospital Boston |
 |
Ingrid Holm, M.D.Clinical Genetics Children's Hospital Boston |
Lewis B. Holmes, M.D.Clinical Genetics Massachusetts General Hospital |
Mira Irons, M.D.Clinical Genetics Children's Hospital Boston Mira Irons, M.D., was the Program Director of the Harvard Medical School Genetics Training Program from January of 2004 until February, 2012. Dr. Irons also served as the Director of the Clinical Genetics Residency from 2003-2011. Dr. Irons received her M.D. from Northwestern University Medical School in Chicago in 1980. She then completed a residency in pediatrics at Children's Memorial Hospital in Chicago. In 1983, she came to Boston to complete a genetics fellowship in the Harvard Medical School Genetics Training Program. After completing her genetics training in 1986, she worked in the Division of Genetics at Tufts University School of Medicine. In 1998, she joined the faculty at Children's Hospital Boston, where she currently serves as Associate Chief of the Division of Genetics and the Chief of Clinical Programs in the Division of Genetics. In this capacity, she oversees all clinical operations of the Division, including the clinical programs in Genetics and Metabolism at the Longwood campus as well as the Children's Hospital satellites. Dr. Irons has a busy clinical practice, is the Director of the Neurofibromatosis Program and also sees patients in her general Genetics clinic, both at the Longwood campus and at the South Shore satellite office. She also serves as the Chair of the Internal Review Committee for the Children’s Hospital GME Program and is a member of the GME Executive Committee at the hospital.Dr. Irons has leadership roles in national Genetics and Medical organizations and/or serves on numerous national medical committees concerning genetics training and/or medical education. She is the President-Elect of the Association of Professors of Human and Medical Genetics, is the Chair of the Medical Genetics Residency Review Committee of the ACGME, is the Chair of the Education Committee and is the CME Officer for the American College of Medical Genetics, and is the ACMG representative to the Council of Medical Specialty Societies. She also is a member of the Accreditation Review Committee of the ACCME. |
Philip James, M.D.Clinical and Biochemical Genetics Children's Hospital Boston |
Natalia Leach, Ph.D.Cytogenetics Brigham and Women's Hospital |
Chrles Lee, Ph.D.Cytogenetics Brigham and Women's Hospital |
Harvey Levy, M.D.Clinical and Biochemical Genetics Children's Hospital Boston Co-Director, Clinical Biochemical Genetics Specialty Harvey Levy, M.D. is co-director of the HMS ABMG Clinical Biochemical Genetics program. Dr. Levy specializes in biochemical genetics (metabolism). He is Senior Physician in Medicine/Genetics at Children's Hospital Boston and Professor of Pediatrics at the Harvard Medical School. He was formerly Director of the Metabolic Program and currently serves as an attending physician within the program. Dr. Levy conducts clinical research in two areas of metabolism, phenylketonuria (PKU) and clinical and biochemical follow-up of newborn screening for metabolic disorders. He has very active research projects ongoing in those areas. |
Azra Ligon, Ph.D.Cytogenetics Brigham and Women's Hospital Director, Clinical Cytogenetics Specialty Azra H. Ligon, Ph.D., oversees training in the HMS ABMG Clinical Cytogenetics program. Dr. Ligon received her Ph.D. in Cancer Biology from the University of Texas/M.D. Anderson Cancer Center in 1995. She completed her Medical Genetics training at Baylor College of Medicine in 1997 and, after a research postdoctoral fellowship at Brigham and Women's Hospital (BWH), joined the Staff of the BWH Cytogenetics Laboratory in 1999 as an ABMG-certified Clinical Cytogeneticist. In 2003, she assumed leadership of the HMS ABMG Cytogenetics training program. Dr. Ligon's research activities include translation of basic research findings into clinical diagnostics, especially those relevant to the area of cancer diagnostics.l |
 |
Angela Lin M.D.Clinical Genetics Massachusetts General Hospital Angela Lin trained in pediatric cardiology and medical genetics. As a clinical geneticist at MassGeneral Hospital for Children, her general genetics clinic is on Friday morning, supplemented by Cardiogenetics Clinic (including the MGH HHT Service), Craniofacial Clinic, Turner Syndrome Clinic, CHARGE Syndrome Clinic, and her interest in Costello and related Ras/MAPK syndromes. She works in the Active Malformation Surveillance Program at the BWH, and works at the MA Dept. Public Health as the geneticist for the Massachusetts Center for Birth Defects Prevention. Her clinical research interest focuses on syndrome delineation, cardiovascular anomalies in syndromes, and the epidemiology of CHDs. Dr. Lin is an Associate Editor for the American Journal of Medical Genetics. She works with several consumer advocacy groups including the Costello Syndrome Family Network and Turner Syndrome Society of America.
|
Neal Lindeman, M.D.Pathology Brigham and Women's Hospital |
Deborah Marsden, M.D.Biochemical Genetics Children's Hospital Boston |
David Miller, M.D., Ph.D.Clinical and Molecular Genetics Children's Hospital Boston |
Cynthia Morton, Ph.D.Cytogenetics Brigham and Women's Hospital Education Director Cynthia Morton, Ph.D. is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Associate Director of the Partners HealthCare Center for Personalized Genetic Medicine, Education Director for the HMS Genetics Training Program and Director of Cytogenetics at Brigham and Women's Hospital. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata, hereditary hearing loss, and cytogenetic approaches to gene discovery for developmental disorders. Her full-time academic laboratory contributed to the development of diagnostic testing for chromosome studies that cross the lifespan, which include preimplantation and prenatal diagnostics, perinatal and childhood studies in the evaluation of congenital and developmental disorders, infertility and pregnancy loss studies, and cytogenetics of leukemias, lymphomas and solid tumors. Her laboratory has been a major site for training laboratory geneticists in clinical cytogenetics. |
Michael Murray, M.D.Clinical Genetics Brigham and Women's Hospital Co-Director, Genetics Medicine Combined Residency, Site Director, Brigham and Women's Hospital Rotation Dr. Murray is the Director of the BWH clinical genetics rotation. He is also the Co-Director of the BWH Genetics Medicine Residency Program along with Joel Katz, M.D. offering combined residency training in Internal Medicine and Medical Genetics. He supervises trainees in clinics and teaches in the Advanced Human Genetics course. His area of interest is the genetics of infectious diseases and connective tissue disease. Dr. Murray has developed and led the Brigham and Women's Family History Project and also developed an annual continuing medical education course offered since 2005, The Genetics and Genomic Basis of Adult Medicine. |
Edward Neilan, M.D., Ph.D.Clinical and Biochemical Genetics Children's Hospital Boston |
Jonathan Picker, M.D.Clinical Genetics Children's Hospital Boston |
Heidi Rehm, Ph.D.Director, Clinical Molecular Genetics SpecialtyHeidi Rehm was recruited in 2001 to build the Laboratory for Molecular Medicine at PCPGM and now serves as its Laboratory Director. She is a board-certified clinical molecular geneticist and Assistant Professor of Pathology at Harvard Medical School with appointments at Brigham & Women’s Hospital, Massachusetts General Hospital and Children’s Hospital Boston. Her undergraduate degree is from Middlebury College, her graduate degree in Genetics is from Harvard University and her postdoctoral and fellowship training was at Harvard |
Amy Roberts, M.D.Clinical Genetics Children's Hospital Boston Co-Director, Pediatrics/Clinical Genetic Residency Combined Training ProgramAmy Roberts, M.D., CHB Department of Cardilogy and Department of Medicine, Division of Genetics |
Yiping Shen, Ph.D.Clinical Molecular Genetics Children's Hospital Boston Massachusetts General Hospital |
Katherine Sims, M.D.Massachusetts General Hospital |
Sharon Smith, M.D.Clinical Genetics Children's Hospital Boston |
Joan Stoler, M.D.Clinical Genetics Children's Hospital Boston |
David Sweetser, M.D.Site Director, Massachusetts General Hospital Clinical RotationClinical Genetics Massachusetts General Hospital |
Wen-Hann Tan, M.D.Clinical Genetics Children's Hospital Boston |
Joseph Thakuria, M.D.Clinical Genetics Massachusetts General Hospital |
 |
Christopher Walsh, M.D., Ph.D.Chief, Division of Genetics Children's Hospital Boston Dr. Walsh is the Chief of the Division of Genetics at Children's Hospital Boston as well as Professor of Neurology and Pediatrics at Harvard Medical School, Associate Member of the Broad Institute, and Senior Associate in Neurology at Beth Israel Deaconess Medical Center. Dr. Walsh is interested in genes that regulate the development and function of the human cerebral cortex. More information can be found here: www.walshlab.org |
Stanislawa Weremowicz, Ph.D.Cytogenetics Brigham and Women's Hospital |
Louise Wilkens-Haug, M.D.Brigham and Women's Hospital |
Bai-Lin Wu, Ph.D.Molecular Genetics Children's Hospital Boston |
Winnie Xin, M.D.Molecular Genetics Massachusetts General Hospital |
Contact Us | Disclaimer
© Copyright Partners HealthCare Center for Personalized Genetic Medicine (PCPGM)
